









Markets
/
Stocks
/
nasdaq-edap
/

Edap Tms SA

EDAP

4.730USD

+0.730+18.25%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

176.86MMarket Cap

LossP/E TTM



Edap Tms SA

4.730

+0.730+18.25%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Edap Tms SA

Currency: USD Updated: 2026-02-06

Key Insights

Edap Tms SA's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 95 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 6.83.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Edap Tms SA's Score

Industry at a Glance

Industry Ranking

95 / 205

Overall Ranking

247 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Edap Tms SA Highlights

StrengthsRisks

Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 17.42% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 59.36M.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 59.36M.

Fairly Valued

The company’s latest PE is -10.61, at a medium 3-year percentile range.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.37.

Analyst Rating

Based on 3 analysts

Hold

Current Rating

6.833

Target Price

+70.83%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Edap Tms SA is 6.66, ranking 139 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 12.02M, representing a year-over-year decrease of 0.86%, while its net profit experienced a year-over-year decrease of 26.69%.

Score

Industry at a Glance

Previous score

6.66

Change



Financials

6.35

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

7.11

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

6.57

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

6.18

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.08

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Edap Tms SA's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Edap Tms SA is 7.34, ranking 94 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -10.61, which is -1075.10% below the recent high of 103.45 and -1376.82% above the recent low of -156.68.

Score

Industry at a Glance

Previous score

7.34

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 95/205

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of Edap Tms SA is 6.67, ranking 164 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 2.00, with a high of 14.00 and a low of 1.50.

Score

Industry at a Glance

Previous score

6.67

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 3 analysts

Hold

Current Rating

6.833

Target Price

+70.83%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Edap Tms SA

EDAP

Intuitive Surgical Inc

ISRG

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Edap Tms SA is 9.21, ranking 11 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 5.28 and the support level at 3.77, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

7.17

Change

2.04

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(2)

Buy(3)

Indicators

Value

Direction

MACD(12,26,9)

0.000

Buy

RSI(14)

67.748

Neutral

STOCH(KDJ)(9,3,3)

68.748

Neutral

ATR(14)

0.427

Low Volatility

CCI(14)

136.050

Buy

Williams %R

9.302

Overbought

TRIX(12,20)

1.039

Sell

StochRSI(14)

81.971

Buy

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

4.315

Buy

MA10

4.235

Buy

MA20

4.057

Buy

MA50

3.348

Buy

MA100

2.796

Buy

MA200

2.288

Buy

Institutional Confidence

Currency: USD Updated: 2026-02-06

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Soleus Capital Management, L.P.

7.31M

Morgan Stanley & Co. International Plc

3.36M

-0.02%

Rock Springs Capital Management LP

1.27M

Bruce & Company, Inc.

438.65K

-20.77%

UBS Financial Services, Inc.

234.44K

+34.22%

Schonfeld Strategic Advisors LLC

170.06K

-1.21%

Parkman Healthcare Partners LLC

154.83K

Cahill Financial Advisors, Inc.

134.96K

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Edap Tms SA is 2.08, ranking 164 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is -0.17. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.